N-[[2-[4-[4-(benzothiazol-2-ylsulfanylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]quinoxaline-2-carboxamide
Molecular Formula:
C42H36N4O4S2
InChI: InChI=1/C42H36N4O4S2/c1-26-37(25-51-42-46-35-12-6-7-13-38(35)52-42)49-41(50-39(26)29-16-14-27(24-47)15-17-29)30-20-18-28(19-21-30)32-9-3-2-8-31(32)22-44-40(48)36-23-43-33-10-4-5-11-34(33)45-36/h2-21,23,26,37,39,41,47H,22,24-25H2,1H3,(H,44,48)/f/h44H
InChIKey: InChIKey=XHXZRXFUKXYHRV-UWJYMYAYCR
SMILES: CC1C(OC(OC1C2=CC=C(C=C2)CO)C3=CC=C(C=C3)C4=CC=CC=C4CNC(=O)C5=NC6=CC=CC=C6N=C5)CSC7=NC8=CC=CC=C8S7
Names:
N-[[2-[4-[4-(benzothiazol-2-ylsulfanylmethyl)-6-[4-(hydroxymethyl)phenyl]-5-methyl-1,3-dioxan-2-yl]phenyl]phenyl]methyl]quinoxaline-2-carboxamide
Registries:
PubChem CID 3565077
PubChem ID 4826801
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|